NFKBIB
NF-kappa-B inhibitor beta
Also known as: IKBB, IKBB_HUMAN, TRIP9
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q15653
- Gene
- NFKBIB
- Ensembl
- ENSG00000104825
- Chromosome
- 19
- Canonical length
- 356 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
The protein encoded by this gene belongs to the NF-kappa-B inhibitor family, which inhibit NF-kappa-B by complexing with, and trapping it in the cytoplasm. Phosphorylation of serine residues on these proteins by kinases marks them for destruction via the ubiquitination pathway, thereby allowing activation of the NF-kappa-B, which translocates to the nucleus to function as a transcription factor. Alternatively spliced transcript variants have been found for this gene.[provided by RefSeq, Jul 2011]
Canonical amino-acid sequenceUniProt
356 residues, UniProt reviewed canonical sequence.
>Q15653|NFKBIB
1 MAGVACLGKA ADADEWCDSG LGSLGPDAAA PGGPGLGAEL GPGLSWAPLV FGYVTEDGDT
61 ALHLAVIHQH EPFLDFLLGF SAGTEYMDLQ NDLGQTALHL AAILGETSTV EKLYAAGAGL
121 CVAERRGHTA LHLACRVGAH ACARALLQPR PRRPREAPDT YLAQGPDRTP DTNHTPVALY
181 PDSDLEKEEE ESEEDWKLQL EAENYEGHTP LHVAVIHKDV EMVRLLRDAG ADLDKPEPTC
241 GRSPLHLAVE AQAADVLELL LRAGANPAAR MYGGRTPLGS AMLRPNPILA RLLRAHGAPE
301 PEGEDEKSGP CSSSSDSDSG DEGDEYDDIV VHSSRSQTRL PPTPASKPLP DDPRPVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NFKBIB can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.39
- Highest tissue expression
- 72 nTPM
Expression across tissuesHPA
Tissue
- testis: 72 nTPM
- skeletal muscle: 28 nTPM
- liver: 20 nTPM
- spinal cord: 16 nTPM
- blood vessel: 16 nTPM
- heart muscle: 15 nTPM
Single-cell type
- late spermatids: 1,279 nCPM
- early spermatids: 896 nCPM
- late primary spermatocytes: 37 nCPM
- syncytiotrophoblasts: 35 nCPM
- enterocytes: 18 nCPM
- epididymal basal cells: 16 nCPM
Immune cell
- eosinophil: 10 nTPM
- neutrophil: 7.5 nTPM
- NK-cell: 7.1 nTPM
- T-reg: 5.9 nTPM
- intermediate monocyte: 4.9 nTPM
- plasmacytoid DC: 4.3 nTPM
Brain region
- white matter: 11 nTPM
- basal ganglia: 11 nTPM
- thalamus: 10 nTPM
- medulla oblongata: 9.8 nTPM
- cerebral cortex: 9.5 nTPM
- midbrain: 9.5 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.56
- gnomAD pLI
- 0.42
- gnomAD missense Z
- 0.97
- DepMap mean gene effect
- -0.13
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 9% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to lipopolysaccharide
- DNA-templated transcription
- inflammatory response
- regulation of canonical NF-kappaB signal transduction
- signal transduction
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NFKBIB in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NFKBIB as an antibody target. Whether an autoantibody or antibody against NFKBIB could matter depends on whether native NFKBIB is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NFKBIB is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label NFKBIB as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...